University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
DNA Annotations Predict Patient Outcomes in Childhood Leukemia

DNA Annotations Predict Patient Outcomes in Childhood Leukemia

December 19, 2017

UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment. The researchers are ...
2018 Precision Medicine World Conference to Feature UCSF Faculty

2018 Precision Medicine World Conference to Feature UCSF Faculty

December 15, 2017

For the third consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) in January 2018 to share the latest in the rapidly evolving space. Renamed from the Personalized Medicine World Conference, the annual forum attracts more than 1,000 recognized authorities and experts to ...
Year in Review: 2017

Year in Review: 2017

December 13, 2017

2017 has been a year of collaboration, innovation, and achievement at the Helen Diller Family Comprehensive Cancer.  As the year winds down, we take a moment to reflect on some highlights. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and families, ...
Collaboration Highlights UCSF Cancer Center's Leadership in Precision Medicine for Prostate Cancer

Collaboration Highlights UCSF Cancer Center's Leadership in Precision Medicine for Prostate Cancer

December 11, 2017

A new collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and the biotechnology company Strata Oncology to provide free genomic testing to men with advanced prostate cancer could help patients nationwide gain access to cutting-edge treatment and lead to new therapies for ...
New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel

New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel "Neoantigen"

December 4, 2017

Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers.
Biochemist Peter Walter Receives 2018 Breakthrough Prize in Life Sciences

Biochemist Peter Walter Receives 2018 Breakthrough Prize in Life Sciences

December 3, 2017

Peter Walter, PhD, professor of biochemistry and biophysics at UC San Francisco, has been named winner of a 2018 Breakthrough Prize in Life Sciences, for his research on a biological mechanism that normally protects cells, but can cause disease if not functioning properly.

Sugar Industry Suppressed Evidence of Health Risks of Sucrose

Sugar Industry Suppressed Evidence of Health Risks of Sucrose

November 21, 2017

The sugar industry buried scientific research almost 50 years ago that pointed to negative health effects of sugar, ceasing funding the research when it reflected negatively on the industry's interests, according to a new UC San Francisco study.

HDFCCC Global Cancer Team Visits Tanzanian Partners

HDFCCC Global Cancer Team Visits Tanzanian Partners

November 16, 2017

In September, Katherine Van Loon, MD, MPH, assistant professor in hematology/oncology and director of the HDFCCC Global Cancer Program, led a group of UCSF faculty and trainees to Tanzania to meet with stakeholders at the Muhimbili University of Health and Allied Sciences (MUHAS) and Ocean Road ...
Cell Mapping Initiatives Aim to Uncover Hidden Pathways of Disease

Cell Mapping Initiatives Aim to Uncover Hidden Pathways of Disease

November 15, 2017

Researchers believe mapping the connections between genes and proteins in many human cell types could hold the answers to understanding diseases from tuberculosis to cancer to autism.

Anna Maria Nápoles Appointed Scientific Director of NIMHD

Anna Maria Nápoles Appointed Scientific Director of NIMHD

November 6, 2017

The National Institute on Minority Health and Health Disparities (NIMHD) has appointed Anna Maria Nápoles, PhD, MPH, as scientific director of its Division of Intramural Research. Nápoles, a UC San Francisco behavioral epidemiologist, is the first Latina to be named a scientific director at the National Institutes of Health.